Transit Analysis for Shuttle Schedule Optimization

Closed Special Notice Posted

Solicitation number
75F40124R00117
Agency
Responses due
Set-aside
Total Small Business

Opportunity facts

NAICS code
485113 Bus and Other Motor Vehicle Transit Systems
PSC
AS11 Transportation R&D Services; Surface Transportation, Public Transit, And Rail; Basic Research
Place of performance
Silver Spring, Maryland 20903, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services Food and Drug Administration (FDA) published a Special Notice for a transit analysis and shuttle schedule optimization project for the FDA White Oak Campus in Silver Spring, Maryland. The objective is to conduct an analysis of transit options in the campus service area, update and modify the FDA commuter and circulator shuttle bus schedules, and provide services where there are gaps in public transit.

The FDA intends to issue a single award from a fair opportunity competition after exclusion of sources for small businesses. Interested parties may identify their interest and capabilities within seven days of the notice publication. The FDA will use the responses to determine if full and open competition is necessary for this requirement. Responses must be submitted by June 17, 2024 at 12:00 PM EST to Natapol Sirikhan at Natapol.Sirikhan@fda.hhs.gov. The proposed acquisition will be set aside for small businesses only.

Notice text

Notice of Fair Opportunity

Small Business Set Aside - After Exclusion of Sources

The US Food and Drug  Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award  from a fair opportunity competition After Exclusion of Sources; to conduct an analysis of all relevant transit options within the FDA White Oak Campus service area, located at 10903 New Hampshire Ave, Silver Spring, Maryland 20993; to update and modify FDA Commuter and Circulator Shuttle Bus schedules servicing the White Oak Campus; based on the results of the analysis with the objective of supplementing the services provided by local public transit agencies; and to provide for service where there are gaps in service provided by public transit agencies.

The propose this acquisition under the exclusion of sources, is for the Government to solicit and negotiate with identified source only. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to compete this proposed acquisition, other than Small Business Set Aside - After Exclusion of Sources, based upon responses to this notice, is solely within the discretion of the Government. 

Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement. No further solicitation is available.

FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by June 17, 2024, 12:00 PM EST.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity